Lupin launches generic Thyroid tablets in The US
India, March 22 -- Pharma major Lupin Limited (Lupin) announced the launch of Levothyroxine Sodium Tablets USP, having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin's Levothyroxine Sodium Tablets USP, is the generic equivalent of AbbVie, Inc's Synthroid(R) Tablets.
It is indicated for Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism.
It is also used for Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer.
Levothyroxine Sodium Tablets, 25 mcg, 5...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.